- call +1-201-465-4211
- email sales@mrinsights.biz
Scope of the Report:
The worldwide market for Spinal Devices and Biologics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Spinal Devices and Biologics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Nuvasive
Orthofix International
Exactech
Wright Medical Group
Johnson & Johnson
Zimmer Biomet
Globus Medical
K2M
Medtronic
Alphatec Holdings
RTI Surgical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Spinal Fusion & Fixation
Motion Preservation
Non-Fusion Technologies
Fracture Treatment
Other
Market Segment by Applications, can be divided into
Hospitals
Ambulatory Surgical Centers
Clinics
Other
There are 15 Chapters to deeply display the global Spinal Devices and Biologics market.
Chapter 1, to describe Spinal Devices and Biologics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Spinal Devices and Biologics, with sales, revenue, and price of Spinal Devices and Biologics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Spinal Devices and Biologics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Spinal Devices and Biologics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Spinal Devices and Biologics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Spinal Devices and Biologics Introduction
1.2 Market Analysis by Type
1.2.1 Spinal Fusion & Fixation
1.2.2 Motion Preservation
1.2.3 Non-Fusion Technologies
1.2.4 Fracture Treatment
1.2.5 Other
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Ambulatory Surgical Centers
1.3.3 Clinics
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Nuvasive
2.1.1 Business Overview
2.1.2 Spinal Devices and Biologics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Nuvasive Spinal Devices and Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Orthofix International
2.2.1 Business Overview
2.2.2 Spinal Devices and Biologics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Orthofix International Spinal Devices and Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Exactech
2.3.1 Business Overview
2.3.2 Spinal Devices and Biologics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Exactech Spinal Devices and Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Wright Medical Group
2.4.1 Business Overview
2.4.2 Spinal Devices and Biologics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Wright Medical Group Spinal Devices and Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Johnson & Johnson
2.5.1 Business Overview
2.5.2 Spinal Devices and Biologics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Johnson & Johnson Spinal Devices and Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Zimmer Biomet
2.6.1 Business Overview
2.6.2 Spinal Devices and Biologics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Zimmer Biomet Spinal Devices and Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Globus Medical
2.7.1 Business Overview
2.7.2 Spinal Devices and Biologics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Globus Medical Spinal Devices and Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 K2M
2.8.1 Business Overview
2.8.2 Spinal Devices and Biologics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 K2M Spinal Devices and Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Medtronic
2.9.1 Business Overview
2.9.2 Spinal Devices and Biologics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Medtronic Spinal Devices and Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Alphatec Holdings
2.10.1 Business Overview
2.10.2 Spinal Devices and Biologics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Alphatec Holdings Spinal Devices and Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 RTI Surgical
2.11.1 Business Overview
2.11.2 Spinal Devices and Biologics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 RTI Surgical Spinal Devices and Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Spinal Devices and Biologics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Spinal Devices and Biologics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Spinal Devices and Biologics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Spinal Devices and Biologics Manufacturer Market Share in 2017
3.3.2 Top 6 Spinal Devices and Biologics Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Spinal Devices and Biologics Market Analysis by Regions
4.1 Global Spinal Devices and Biologics Sales, Revenue and Market Share by Regions
4.1.1 Global Spinal Devices and Biologics Sales and Market Share by Regions (2013-2018)
4.1.2 Global Spinal Devices and Biologics Revenue and Market Share by Regions (2013-2018)
4.2 North America Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
4.3 Europe Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
4.5 South America Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
5 North America Spinal Devices and Biologics by Countries
5.1 North America Spinal Devices and Biologics Sales, Revenue and Market Share by Countries
5.1.1 North America Spinal Devices and Biologics Sales and Market Share by Countries (2013-2018)
5.1.2 North America Spinal Devices and Biologics Revenue and Market Share by Countries (2013-2018)
5.2 United States Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
5.3 Canada Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
5.4 Mexico Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
6 Europe Spinal Devices and Biologics by Countries
6.1 Europe Spinal Devices and Biologics Sales, Revenue and Market Share by Countries
6.1.1 Europe Spinal Devices and Biologics Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Spinal Devices and Biologics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
6.3 UK Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
6.4 France Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
6.5 Russia Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
6.6 Italy Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
7 Asia-Pacific Spinal Devices and Biologics by Countries
7.1 Asia-Pacific Spinal Devices and Biologics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Spinal Devices and Biologics Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Spinal Devices and Biologics Revenue and Market Share by Countries (2013-2018)
7.2 China Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
7.3 Japan Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
7.4 Korea Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
7.5 India Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
8 South America Spinal Devices and Biologics by Countries
8.1 South America Spinal Devices and Biologics Sales, Revenue and Market Share by Countries
8.1.1 South America Spinal Devices and Biologics Sales and Market Share by Countries (2013-2018)
8.1.2 South America Spinal Devices and Biologics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
8.3 Argentina Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
8.4 Colombia Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
9 Middle East and Africa Spinal Devices and Biologics by Countries
9.1 Middle East and Africa Spinal Devices and Biologics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Spinal Devices and Biologics Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Spinal Devices and Biologics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
9.3 UAE Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
9.4 Egypt Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
9.5 Nigeria Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
9.6 South Africa Spinal Devices and Biologics Sales and Growth Rate (2013-2018)
10 Global Spinal Devices and Biologics Market Segment by Type
10.1 Global Spinal Devices and Biologics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Spinal Devices and Biologics Sales and Market Share by Type (2013-2018)
10.1.2 Global Spinal Devices and Biologics Revenue and Market Share by Type (2013-2018)
10.2 Spinal Fusion & Fixation Sales Growth and Price
10.2.1 Global Spinal Fusion & Fixation Sales Growth (2013-2018)
10.2.2 Global Spinal Fusion & Fixation Price (2013-2018)
10.3 Motion Preservation Sales Growth and Price
10.3.1 Global Motion Preservation Sales Growth (2013-2018)
10.3.2 Global Motion Preservation Price (2013-2018)
10.4 Non-Fusion Technologies Sales Growth and Price
10.4.1 Global Non-Fusion Technologies Sales Growth (2013-2018)
10.4.2 Global Non-Fusion Technologies Price (2013-2018)
10.5 Fracture Treatment Sales Growth and Price
10.5.1 Global Fracture Treatment Sales Growth (2013-2018)
10.5.2 Global Fracture Treatment Price (2013-2018)
10.6 Other Sales Growth and Price
10.6.1 Global Other Sales Growth (2013-2018)
10.6.2 Global Other Price (2013-2018)
11 Global Spinal Devices and Biologics Market Segment by Application
11.1 Global Spinal Devices and Biologics Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Ambulatory Surgical Centers Sales Growth (2013-2018)
11.4 Clinics Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Spinal Devices and Biologics Market Forecast (2018-2023)
12.1 Global Spinal Devices and Biologics Sales, Revenue and Growth Rate (2018-2023)
12.2 Spinal Devices and Biologics Market Forecast by Regions (2018-2023)
12.2.1 North America Spinal Devices and Biologics Market Forecast (2018-2023)
12.2.2 Europe Spinal Devices and Biologics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Spinal Devices and Biologics Market Forecast (2018-2023)
12.2.4 South America Spinal Devices and Biologics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Spinal Devices and Biologics Market Forecast (2018-2023)
12.3 Spinal Devices and Biologics Market Forecast by Type (2018-2023)
12.3.1 Global Spinal Devices and Biologics Sales Forecast by Type (2018-2023)
12.3.2 Global Spinal Devices and Biologics Market Share Forecast by Type (2018-2023)
12.4 Spinal Devices and Biologics Market Forecast by Application (2018-2023)
12.4.1 Global Spinal Devices and Biologics Sales Forecast by Application (2018-2023)
12.4.2 Global Spinal Devices and Biologics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Spinal Devices and Biologics Picture
Table Product Specifications of Spinal Devices and Biologics
Figure Global Sales Market Share of Spinal Devices and Biologics by
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
